{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:23:00Z","timestamp":1790662980058,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774240"],"award-info":[{"award-number":["81774240"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074154"],"award-info":[{"award-number":["82074154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jconrel.2022.05.057","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T23:50:48Z","timestamp":1654645848000},"page":"250-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer"],"prefix":"10.1016","volume":"348","author":[{"given":"Shulan","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2021","key":"10.1016\/j.jconrel.2022.05.057_bb0005","first-page":"209","article-title":"GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.msec.2018.05.011","article-title":"Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL\/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma","volume":"91","author":"Gan","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2017.02.128","article-title":"IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model","volume":"486","author":"Liu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0020","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.7150\/thno.42998","article-title":"Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0025","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1158\/1078-0432.CCR-17-0950","article-title":"Characterization of the immune microenvironment in hepatocellular carcinoma","volume":"23","author":"Yarchoan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0030","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/acsnano.0c00708","article-title":"Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma","volume":"14","author":"Yu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0035","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.7150\/thno.38425","article-title":"Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy","volume":"9","author":"Lim","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0040","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.7150\/thno.42243","article-title":"Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity","volume":"10","author":"Sethuraman","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.drudis.2020.11.029","article-title":"Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy","volume":"26","author":"Sun","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0050","first-page":"1365","article-title":"High-density lipoprotein-mimicking nanodiscs for chemo-immunotherapy against glioblastoma multiforme","volume":"13","author":"Kadiyala","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120333","article-title":"Enhancing TNBC chemo-immunotherapy via combination reprogramming tumor immune microenvironment with immunogenic cell death","volume":"598","author":"Wu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-319-67577-0_7","article-title":"Chemo-immunotherapy: role of indoleamine 2,3-dioxygenase in defining immunogenic versus tolerogenic cell death in the tumor microenvironment","volume":"1036","author":"Johnson","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0065","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1158\/0008-5472.CAN-11-0950","article-title":"Human tumor cells killed by anthracyclines induce a tumor-specific immune response","volume":"71","author":"Fucikova","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0070","doi-asserted-by":"crossref","first-page":"17109","DOI":"10.1038\/nplants.2017.109","article-title":"Demystifying traditional herbal medicine with modern approach","volume":"3","author":"Li","year":"2017","journal-title":"Nat. Plants"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0075","doi-asserted-by":"crossref","first-page":"45276","DOI":"10.1021\/acsami.9b16047","article-title":"Nanoparticles mediating the sustained puerarin release facilitate improved brain delivery to treat Parkinson\u2019s disease","volume":"11","author":"Chen","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0080","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2174\/1389450116666150309122334","article-title":"Nano traditional Chinese medicine: current progresses and future challenges","volume":"16","author":"Huang","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0085","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1872-034X.2009.00540.x","article-title":"Plumbagin inhibits invasion and migration of liver cancer HepG2 cells by decreasing productions of matrix metalloproteinase-2 and urokinase- plasminogen activator","volume":"39","author":"Shih","year":"2009","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1142\/S0192415X17500264","article-title":"Anticancer properties and pharmaceutical applications of Plumbagin: a review","volume":"45","author":"Liu","year":"2017","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173227","article-title":"Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: a systematic pharmacology study","volume":"881","author":"Liang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-020-01297-0","article-title":"Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma","volume":"20","author":"Guo","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0105","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1038\/s41467-020-18745-6","article-title":"Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death","volume":"11","author":"Deng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0110","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0115","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-019-11269-8","article-title":"Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0120","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1021\/acs.nanolett.9b05210","article-title":"Endoplasmic reticulum targeting to amplify immunogenic cell death for cancer immunotherapy","volume":"20","author":"Deng","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0125","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.phymed.2015.08.009","article-title":"Dihydrotanshinone I induced apoptosis and autophagy through caspase dependent pathway in colon cancer","volume":"22","author":"Wang","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104254","article-title":"Pharmacological activities of dihydrotanshinone I, a natural product from salvia miltiorrhiza Bunge","volume":"145","author":"Chen","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0135","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.31557\/APJCP.2021.22.7.2177","article-title":"Dihydrotanshinone-I modulates epithelial mesenchymal transition (EMT) thereby impairing migration and clonogenicity of triple negative breast cancer cells","volume":"22","author":"Kashyap","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.partic.2017.06.008","article-title":"Dual-function baicalin and baicalin-loaded poly(lactic-co-glycolic acid) nanoparticles: immune activation of dendritic cells and arrest of the melanoma cell cycle at the G2\/M phase","volume":"37","author":"Wang","year":"2018","journal-title":"Particuology"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2019.02.013","article-title":"Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice","volume":"137","author":"Luan","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0150","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/acs.molpharmaceut.6b01150","article-title":"Antibody-targeted cyclodextrin-based nanoparticles for siRNA delivery in the treatment of acute myeloid leukemia: physicochemical characteristics, in vitro mechanistic studies, and ex vivo patient derived therapeutic efficacy","volume":"14","author":"Guo","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0155","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0160","doi-asserted-by":"crossref","first-page":"20206","DOI":"10.1039\/C9NR03353J","article-title":"Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages","volume":"11","author":"Han","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0165","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.7150\/thno.45028","article-title":"Engineering blood exosomes for tumor-targeting efficient gene\/chemo combination therapy","volume":"10","author":"Zhan","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0170","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1039\/c3nr03064d","article-title":"Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles","volume":"5","author":"Fang","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0175","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1021\/acsnano.5b01042","article-title":"Erythrocyte membrane-enveloped polymeric nanoparticles as Nanovaccine for induction of antitumor immunity against melanoma","volume":"9","author":"Guo","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0180","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1021\/nn5066793","article-title":"pH-Responsive poly(D,L-lactic-co-glycolic acid) nanoparticles with rapid antigen release behavior promote immune response","volume":"9","author":"Liu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s11671-016-1509-3","article-title":"Highly stable PEGylated poly(lactic-co-glycolic acid) (PLGA) nanoparticles for the effective delivery of docetaxel in prostate cancers","volume":"11","author":"Cao","year":"2016","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0190","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1039\/D0BM00825G","article-title":"Biocompatible melanin based theranostic agent for in vivo detection and ablation of orthotopic micro-hepatocellular carcinoma","volume":"8","author":"Chen","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0195","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010058","article-title":"A systems biological view of life-and-death decision with respect to endoplasmic reticulum stress-the role of PERK pathway","volume":"18","author":"Marton","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.493","article-title":"Strange attractors: DAMPs and autophagy link tumor cell death and immunity","volume":"4","author":"Hou","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2018.09.022","article-title":"Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma","volume":"70","author":"Chen","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-62703-218-6_26","article-title":"Monitoring dendritic cell activation and maturation","volume":"960","author":"Fancke","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0225","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12026-017-8931-1","article-title":"Dendritic cell-based immunotherapy: a basic review and recent advances","volume":"65","author":"Constantino","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0230","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","article-title":"Reactive oxygen species, cellular redox systems, and apoptosis","volume":"48","author":"Circu","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0235","first-page":"2977","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"2016","author":"Redza-Dutordoir","year":"1863","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0240","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41565-019-0570-3","article-title":"Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies","volume":"14","author":"Sung","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2020.05.005","article-title":"Membrane-core nanoparticles for cancer nanomedicine","volume":"156","author":"Guo","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0250","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1039\/C9BM01444F","article-title":"Biomimetic cell-derived nanocarriers for modulating immune responses","volume":"8","author":"Qin","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0255","doi-asserted-by":"crossref","first-page":"eaax5032","DOI":"10.1126\/sciadv.aax5032","article-title":"Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer","volume":"6","author":"Huang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0260","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1021\/acsnano.0c01676","article-title":"Nano codelivery of oxaliplatin and folinic acid achieves synergistic chemo-immunotherapy with 5-fluorouracil for colorectal cancer and liver metastasis","volume":"14","author":"Guo","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2021.11.041","article-title":"Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy","volume":"341","author":"Chen","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2022.04.048","article-title":"ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy","volume":"347","author":"Wei","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0275","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2021.06.005","article-title":"A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0280","doi-asserted-by":"crossref","DOI":"10.1177\/1073274819846593","article-title":"MiR-942-3p promotes the proliferation and invasion of hepatocellular carcinoma cells by targeting MBL2","volume":"26","author":"Xu","year":"2019","journal-title":"Cancer Control"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092027","article-title":"Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers","volume":"9","author":"Kaps","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0290","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1002\/adma.201300638","article-title":"Surface functionalization of gold nanoparticles with red blood cell membranes","volume":"25","author":"Gao","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0295","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1021\/acsnano.7b08355","article-title":"Erythrocyte-cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal\/chemotherapy of melanoma","volume":"12","author":"Wang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0300","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0305","article-title":"Biomineralized bacterial outer membrane vesicles potentiate safe and efficient tumor microenvironment reprogramming for anticancer therapy","volume":"32","author":"Qing","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.05.057_bb0310","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jconrel.2020.05.042","article-title":"Cytosolic delivery of HBsAg and enhanced cellular immunity by pH-responsive liposome","volume":"324","author":"Hu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0315","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jconrel.2021.06.001","article-title":"A clinically acceptable strategy for sensitizing anti-PD-1 treatment by hypoxia relief","volume":"335","author":"Jiang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0320","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jconrel.2022.02.018","article-title":"MMP-responsive transformation nanomaterials with IAP antagonist to boost immune checkpoint therapy","volume":"343","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.057_bb0325","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41467-022-29388-0","article-title":"Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:24:35Z","timestamp":1759163075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922003285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":65,"alternative-id":["S0168365922003285"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.057","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}